TransMedics Group (TMDX) PT Lowered to $65 at Stifel

August 5, 2026 8:24 AM

Stifel analyst Thomas Stephan lowered the price target on TransMedics Group (NASDAQ: TMDX) to $65.00 (from $80.00) while maintaining a Hold rating.

No results found